Sponsor Achieves Inspection Ready State in Less Than 8 Weeks Across 70+ Studies

Top 10 Pharmaceutical Sponsor Partners with Trifecta & Veeva for a more Complete, Inspection Ready State in < 8 Weeks Executive Summary Customer Top 10 Pharmaceutical Sponsor Scope Automated transfer of all investigator training records, certificates of attendance and supporting documentation from Trifecta InvestigatorSpace® to Veeva Vault locations. Timing Aggressive — Less than 8 weeks to deliver […]

Improve Training, Increase Participation, Reduce Redundancy, & Cut Costs: Why Virtual Site Training is the New Norm

The use of virtual training through web-based meetings existed long before COVID-19, but the pandemic made web-based on-demand training the new norm, particularly for clinical trials. This shift allows us to compare online site training to in-person training, and the results are dramatic. Based on our work with clients, WCG found that delivering on-demand training […]

What is a CQMS? And Why Do We Need Another Acronym?

As the clinical technology stack gets ever more complex and diverse in its offerings, one must not lose focus on the details. You can procure all the ‘best-in-class’ clinical technologies and still end up frustrated and wondering where the promise of simplicity and automation went. We’ve spoken to many successful colleagues and thought leaders across […]

Virtual Clinical Trial Training FAQs

The use of virtual training existed long before COVID-19, but the pandemic made web-based on-demand training a necessity. As on-demand training and virtual investigator meetings become more common, sites, sponsors and other stakeholders have many questions on the subject. Here are a few of the most common questions we receive on virtual clinical trial training: […]

Top 3 Ways to Take Your Live Clinical Investigator Meeting to the Next Level

As someone responsible for the success of an upcoming investigator meeting, many questions may be running through your mind. Among them, how to keep an advanced group of investigators and study teams engaged throughout the investigator meeting? Even more, how to help audiences retain critical information required to achieve study success and reduce the chance of misunderstanding? […]

Mini-Case Study – A COVID-19 Rapid Response Story

We all know adjusting to the new reality with COVID-19 has been challenging, but it hasn’t been without its rewards. Last week WCG quite literally “answered the call” from a top 10 pharmaceutical company looking to launch an observational Coronavirus study in 24 hours. No, that’s not a typo. Think Jack Bauer, but behind a […]

Making Time for What Matters Most: 5 Key Questions to Ask when Evaluating a Hybrid Training Approach

This is the first of a two-part blog series of how to create more efficiency in your clinical trial training efforts using hybrid training approaches that can save time while reducing complexity and redundancy in clinical trial training. Training. A crucial step in the critical path of study start-up, and on paper, a seemingly straightforward […]

InvestigatorSpace Rapid Reporting Enhancements to Support COVID-19 Trial

The Challenge The complexities of rapidly changing the way in which investigators are trained when supporting a COVID-19 trial resulted in a significant reporting gap for our client. While traditionally, sites could be pre-identified and neatly grouped into roles with very predictable timelines and training plans; the reality of chasing COVID-19 patients, coupled with activating […]

InvestigatorSpace Cross-Sponsor Mutually Recognized Training

WCG has developed and implemented cross-sponsor Mutually Recognized Training, providing immediate impact on costs and reduction of redundant training. THE CHALLENGE The requirement was documentation of ICH-GCP training for all site staff associated with the execution of the protocol. Cross-Sponsor Mutually Recognized Training Exemption of ICH-GCP topic was approved meaning that if the unique user […]

Common Challenges in Endpoint Assessment Training

Endpoint assessment management is an often-cited pain point for both Sponsors and Immuno-dermatology Investigators. This can happen because Dermatology Rater Scale designs are inconsistent and are often recreated on a study-by-study basis – even when there is no scientific reason to do so. The stakes are high for improperly prepared raters. Deviations and variance can […]

Viewing 1 - 10 of 27 articles